Enhancing the viability of preclinical expectations human drugs reactions is critical to reducing expensive failures in clinical trials. The pharmaceutical industry is confronting phenomenal challenges attributable to increasing expenses and the declining efficiency of drug research and development. Late advances in microfabrication, cell biology and microfluidics has empowered the improvement of micro-engineered models of the useful parts of human body known as the organ on chip. 

Organs on chip are micro-engineered biometric systems that imitate the main purpose of living organs. These micro-devices give a more precise model than traditional cell culture for recreating composite cell-matrix and cell-cell collaborations. In this manner, they possibly represent a fascinating tool for chemical and pharmaceutical applications. They additionally permit to contemplate human physiology for a particular organ and in this way empower the improvement of a novel in vitro disease models. Several research activities have been conducted by the different companies and research institutes to bring this advanced technology to the market. Currently, there are limited companies involved in the development of organ on chip, but it is expected that the number of players will increase in the future. 

The purpose of this research study titled ‘Organ on Chip Market - Growth, Future Prospects and Competitive Analysis, 2018 – 2026’ is to offer stakeholders, manufactures, business representatives and industry sponsors with exhaustive exploration to allow them to take planned initiatives and resolutions allied to the expectations in the global organ on chip market. This report presents and assesses the chief scenarios in the overall organ on chip market and the market size and forecast. 

This report classifies the worldwide organ on chip market in terms of products, end users, and geographical distribution. Based on product types, the global organ on chip market is classified into lungs on chip, heart on chip, liver on chip, kidney on chip, and others. The end users considered for the purpose of this study are research institutes and pharmaceutical manufacturers. Market size and forecast for every cited division for the period from 2016 to 2026 are offered in the report alongside particular CAGRs for the forecast period from 2018 to 2026.

This study covers a thorough depiction of the above-indicated market segments for the duration from 2016 to 2026. 

An exhaustive investigation of market situations has been provided in the report to get a proper comprehension of the market and the associated trends. Various tools are utilized in the report to decide the competition between foremost market players. The study additionally contains company profiling of the market players having a prominent hold on the overall organ on chip market market. Some of the foremost players in the global organ on chip market recorded in this study are: Ascendance Biotechnology, CN Bio Innovations, Emulate, Inc          ., HµREL Corporation, Insphero AG, MIMETAS B.V., Nortis Inc., TARA Biosystems, Inc., and TissUse GmbH.

Cumulative burden of growing incidences of heart and kidney related disorders will help in driving the organ on chip market. Lungs on chip dominated the market in 2017 and it is anticipated to continue its supremacy in the forecast period 2018-2026. The heart on chip segment has higher potential for growth as it is the fastest growing market. The organ on chip market will experience an impressive growth rate mostly due to surge in aged population, along with growth in the number of patients suffering from lungs and heart diseases, and the growing need for new technologies to be used as novel tools in drug discovery and development. Amplified skills and consciousness has also resulted in growing acceptance of novel and enhanced technologies by physicians for disease diagnosis. Rapid evolution of healthcare sector and advancement in technology are therefore some of the selected drivers for the rise of the global organ on chip market.

Among the considered usage areas, organ on chip technology enjoys the largest application in research institutes followed by pharmaceutical manufacturers. Higher affordability of research institutes for uptake of organ on chip, greater handling skills and new drug discovery are the foremost factors driving the organ on chip market in research institutes. It is further anticipated that the growing preference for early drug testing results and the need of more reliable data will enhance the demand for organ on chip during the forecast period. Therefore it is predictable that the growth of research institutes sector will be greater than the global benchmark during the forecast period.

Geographically, the global organ on chip market is composed of Latin America, Middle East & Africa, Europe, Asia Pacific, and North America. 

North America holds the major share in global organ on chip market trailed by Europe. Major reasons for the incumbent status of these regions are them being early adopters of new advanced technologies, presence a huge consumer base, and higher organ transplant rate. Furthermore, Asia Pacific is a remunerative market for the companies involved in organ on chip market. Though, widespread commercialization of this technology is not expected to happen in early years, as the market is still in initial stage in developed regions, it would take a couple of years before organizations can assume return on benefit. China and Japan are main market in the region. Need for advanced testing and research technologies and time saving techniques will enhance the market growth in the future. In the course of forecast duration 2018 to 2026, Europe is observed as the fastest growing region followed by Asia Pacific.

Historical & Forecast Period

This study report represents analysis of each segment from 2022 to 2032 considering 2023 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2024 to 2032.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Organ on Chip market are as follows:

• Research and development budgets of manufacturers and government spending
• Revenues of key companies in the market segment
• Number of end users and consumption volume, price and value.
• Geographical revenues generate by countries considered in the report
• Micro and macro environment factors that are currently influencing the Organ on Chip market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Key questions answered in this report

• What are the key micro and macro environmental factors that are impacting the growth of Organ on Chip market?
• What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
• Estimated forecast and market projections up to 2032.
• Which segment accounts for the fastest CAGR during the forecast period?
• Which market segment holds a larger market share and why?
• Are low and middle-income economies investing in the Organ on Chip market?
• Which is the largest regional market for Organ on Chip market?
• What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
• Which are the key trends driving Organ on Chip market growth?
• Who are the key competitors and what are their key strategies to enhance their market presence in the Organ on Chip market worldwide?